Skip to Main Content

Paper Details

Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated inâ¿¿~â¿¿200,000 patients.
Breast Cancer Res
0
2022
contralateral breast cancer, patients
Author NameAffiliation
Peter A FaschingDavid Geffen School of Medicine, University of California at Los Angeles
Peter A FaschingComprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU)
Jonine D FigueroaThe University of Edinburgh
Jonine D FigueroaNational Cancer Institute, National Institutes of Health
Jonine D FigueroaThe University of Edinburgh
Jonine D FigueroaThe University of Edinburgh
Jonine D FigueroaThe University of Edinburgh
Jonine D FigueroaNational Cancer Institute, National Institutes of Health
Montserrat Garcia-ClosasNational Cancer Institute, National Institutes of Health
Montserrat Garcia-ClosasNational Cancer Institute, National Institutes of Health
Christopher A HaimanKeck School of Medicine, University of Southern California
Christopher A HaimanKeck School of Medicine, University of Southern California
Graham G GilesThe University of Melbourne
Jan LubinskiPomeranian Medical University
Jan LubinskiPomeranian Medical University
Maria Elena MartinezMoores Cancer Center, University of California San Diego
Maria Elena MartinezHerbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Jenny Chang-ClaudeGerman Cancer Research Center (DKFZ)
Jenny Chang-ClaudeUniversity Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf
Per HallKarolinska Institutet
Per Hall
Douglas F EastonUniversity of Cambridge
Douglas F EastonUniversity of Cambridge
Ewout W SteyerbergLeiden University Medical Center
Ewout W SteyerbergErasmus MC Cancer Institute
  • 1 - 29

Datasets